Exponent (EXPO) CEO Catherine Corrigan Sells $235K of Stock

Catherine Corrigan, the President and CEO of Exponent, Inc. (NasdaqGS: EXPO), sold 4,119 shares of the company on June 15, 2026. The shares were sold at an average price of $57.13 each, totaling $235,318. This transaction was part of a planned sale.

Insider Buying and Selling at Exponent, Inc.

Catherine Corrigan, as Exponent's CEO, executed a planned sale of 4,119 shares on June 15, 2026. Additionally, on the same day, she sold 5,605 shares in an unplanned transaction and bought 5,605 shares at an average price of $26.96. Other insiders, including Debra Zumwalt and George Brown, bought 2,859 shares each on June 4, 2026.

Other Institutional Activity in Exponent, Inc.

Among Exponent's institutional investors, BlackRock, Inc. reduced its holdings by 95,655 shares, leaving it with 6,068,812 shares valued at about $395.99 million. Kayne Anderson Rudnick Investment Management also trimmed its position by 256,799 shares, ending with 3,886,308 shares worth $253.58 million. In contrast, Vanguard Portfolio Management LLC made a substantial addition, acquiring 2,946,756 shares, bringing its total to 2,946,756 shares valued at approximately $192.28 million. State Street Corp increased its holdings slightly by 33,910 shares, now holding 1,889,536 shares worth $123.29 million.

Exponent, Inc. Stock Down 16.0%

Shares of Exponent, Inc. (EXPO) traded around $57.34. The company has a market capitalization of $2.78 billion and a P/E ratio of 26.79, with a forward P/E of 20.78. It has a beta of 0.73, indicating lower volatility compared to the market. The stock's 52-week range is between $51.91 and $81.95, with a 50-day moving average of $61.69 and a 200-day moving average of $68.29. Exponent maintains a current ratio of 2.40 and a quick ratio of 2.22, with a debt-to-equity ratio of 23.95.

Recent Earnings

In its latest earnings report, Exponent, Inc. reported revenue of $551.14 million, reflecting a growth of 10.5%. The company's net margin stood at 19.76%, with a return on equity of 27.94%. Earnings per share (EPS) were $2.14. The next earnings release is scheduled for July 30, 2026.

Dividend

Exponent, Inc. offers an annual dividend rate of $1.22, yielding 2.13%. The dividend payout ratio is 56.54%.

Analysts Set New Price Targets

On May 15, 2026, JP Morgan maintained its 'buy' rating on Exponent, Inc. with a price target of $80. UBS maintained a 'hold' rating with a target of $75 on May 1, 2026. The consensus among analysts is a 'buy' recommendation, with an average target price of $81.67 from three analyst opinions.

About Exponent, Inc.

Exponent, Inc. is a consulting firm based in Menlo Park, California, offering services in science and engineering. The company operates under two segments: Engineering and Other Scientific, and Environmental and Health. Exponent provides expertise in areas such as biomechanics, civil engineering, data sciences, and environmental sciences, serving clients across various industries including chemicals, construction, and technology. Founded in 1967, the company is led by CEO Dr. Catherine Ford Corrigan.

Bottom Line

Catherine Corrigan's planned share sale is a routine part of her financial management as CEO of Exponent, Inc. Investors track these insider transactions for potential insights into the company's operations. However, it's important to remember that insider sales do not necessarily indicate negative prospects for the company. Exponent remains a key player in the engineering and consulting sector, with robust financials and a diverse client base.